Ethypharm (Paris, France) announced...
Ethypharm (Paris, France) announced positive Phase 2 trial follows for its novel 5-fluorouracil (5-FU) rnicrospheres for the local treatment, following surgical resection, of make subordinates with glioblastoma. The randomized clinical trial was a comparative thought which evaluated the production and radiotherapy versus radiotherapy alone, in 77 enthralls following complete surgical
|